X4 Pharmaceuticals, Inc. (XFOR)
USD 0.64
(-13.21%)
USD 0.64
(-13.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -96.51 Million | -77.1 Million | -70.9 Million | -58.81 Million | -48.05 Million | -40.9 Million |
| Net Income | -101.16 Million | -93.86 Million | -88.69 Million | -62.13 Million | -52.8 Million | -43.02 Million |
| Depreciation & Amortization | 1.99 Million | 513 Thousand | 499 Thousand | 351 Thousand | 103 Thousand | 155 Thousand |
| Deferred income taxes | -1.23 Million | - | -6.67 Million | -5.77 Million | -2.15 Million | - |
| Stock-based compensation | 8.68 Million | 5.19 Million | 6.18 Million | 5.42 Million | 2.05 Million | 5.62 Million |
| Change in working capital | 344 Thousand | 5.73 Million | -1.49 Million | -4.06 Million | -3.23 Million | -4.46 Million |
| Other non-cash items | -5.13 Million | 5.31 Million | 19.28 Million | 7.37 Million | 7.98 Million | 804 Thousand |
| Investing Cash Flow | -14.88 Million | -103 Thousand | -615 Thousand | -1.36 Million | 27.23 Million | -34 Thousand |
| Investments in PPE | -60 Thousand | -103 Thousand | -615 Thousand | -1.36 Million | -174 Thousand | -34 Thousand |
| Acquisitions | 14.82 Thousand | - | - | - | 26.4 Million | - |
| Investment purchases | -16.82 Million | -4.8 Million | - | - | - | - |
| Sales/Maturities of investments | 2 Million | - | - | - | - | - |
| Other Investing Activities | -14.82 Thousand | 4.8 Million | - | - | 1 Million | - |
| Financing Cash Flow | 88.51 Million | 117.23 Million | 74.24 Million | 12.39 Million | 140.66 Million | -4.53 Million |
| Debt repayment | -20.43 Million | -795 Thousand | - | -12.38 Million | -9.36 Million | -4.66 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -12.00 | -2 Million | -277 Thousand | 19.95 Million | -1.12 Million |
| Common Stock Issuance | 68.08 Million | 122.63 Million | 75.98 Million | -277 Thousand | 139.38 Million | 4.46 Million |
| Other Financing Activities | 40.87 Million | -4.6 Million | 260 Thousand | 37.72 Million | 10.64 Million | 136 Thousand |
| Accounts receivables | -1.37 Million | -610 Thousand | - | - | - | -1.37 Million |
| Accounts payables | 1.23 Million | 3.42 Million | 1.16 Million | 1.03 Million | -2.75 Million | -1.33 Million |
| Inventory | - | 610 Thousand | - | - | - | - |
| Other working capital | 480 Thousand | 2.31 Million | -2.66 Million | -5.09 Million | -484 Thousand | -3.12 Million |
| Cash at beginning of period | 122 Million | 83.1 Million | 80.7 Million | 128.08 Million | 8.49 Million | 77.14 Million |
| Cash at end of period | 99.46 Million | 123.02 Million | 83.1 Million | 80.7 Million | 128.08 Million | 31.39 Million |
| Capital Expenditure | -60 Thousand | -103 Thousand | -615 Thousand | -1.36 Million | -174 Thousand | -34 Thousand |
| Effect of forex changes on cash | 99 Thousand | -105 Thousand | -319 Thousand | 402 Thousand | -250 Thousand | -286 Thousand |
| Net cash flow / Change in cash | -22.53 Million | 39.92 Million | 2.4 Million | -47.38 Million | 119.58 Million | -45.75 Million |
| Free Cash Flow | -96.57 Million | -77.2 Million | -71.52 Million | -60.18 Million | -48.22 Million | -40.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 90.83 Million | -51.76 Million | -101.16 Million | -19.13 Million | -2.3 Million | -55.71 Million |
| Depreciation & Amortization | 194 Thousand | 62 Thousand | 1.99 Million | 62 Thousand | 104 Thousand | 126 Thousand |
| Deferred income taxes | - | - | -1.23 Million | -1.85 Million | -25.16 Million | -2.26 Million |
| Stock-based compensation | 2.42 Million | 1.73 Million | 8.68 Million | 2.53 Million | 2.36 Million | 2.14 Million |
| Change in working capital | 1.04 Million | 2.08 Million | 344 Thousand | -5.35 Million | 3.54 Million | 1.54 Million |
| Other non-cash items | -121.01 Million | 16.13 Million | -5.13 Million | -4 Million | 636 Thousand | 32.74 Million |
| Investing Cash Flow | 96.86 Million | -5.32 Million | -14.88 Million | -4.83 Million | -5.15 Million | -4.88 Million |
| Investments in PPE | -134 Thousand | -59 Thousand | -60 Thousand | -35 Thousand | -8000.00 | -8000.00 |
| Acquisitions | - | - | 14.82 Thousand | 4798.00 | -1 Million | - |
| Investment purchases | -3 Million | -10.26 Million | -16.82 Million | -5.79 Million | -6.14 Million | -4.87 Million |
| Sales/Maturities of investments | 2 Million | 5 Million | 2 Million | 1 Million | 1 Million | - |
| Other Investing Activities | 105 Million | -59 Thousand | -14.82 Thousand | -4798.00 | 1 Million | -4876.00 |
| Financing Cash Flow | 20.15 Million | - | 88.51 Million | 97 Thousand | 21.2 Million | 69.33 Million |
| Debt repayment | -20 Million | - | -20.43 Million | -2.06 Million | -383 Thousand | -381 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | 281.00 | -281.00 | 443 Thousand |
| Common Stock Issuance | 159 Thousand | - | 68.08 Million | 97 Thousand | -8.89 Million | 68.89 Million |
| Other Financing Activities | 159 Thousand | - | 40.87 Million | 97.00 | 30.48 Million | 69.33 Thousand |
| Accounts receivables | - | - | -1.37 Million | - | - | - |
| Accounts payables | -948 Thousand | 4000.00 | 1.23 Million | 808 Thousand | 3.24 Million | -1.1 Million |
| Inventory | -831 Thousand | - | - | - | - | - |
| Other working capital | 2.82 Million | 2.08 Million | 480 Thousand | -6.16 Million | 299 Thousand | 2.64 Million |
| Cash at beginning of period | 60.49 Million | 99.46 Million | 122 Million | 131.83 Million | 137.45 Million | 94.43 Million |
| Cash at end of period | 147.21 Million | 60.49 Million | 99.46 Million | 99.46 Million | 132.6 Million | 137.45 Million |
| Capital Expenditure | -134 Thousand | -59 Thousand | -60 Thousand | -35 Thousand | -8000.00 | -8000.00 |
| Effect of forex changes on cash | -18 Thousand | -59 Thousand | 99 Thousand | 127 Thousand | -72 Thousand | -6000.00 |
| Net cash flow / Change in cash | 86.72 Million | -38.97 Million | -22.53 Million | -32.36 Million | -4.85 Million | 43.02 Million |
| Free Cash Flow | -30.41 Million | -33.65 Million | -96.57 Million | -27.78 Million | -20.83 Million | -21.43 Million |
BCHHF
ALPEKA
CTV
AGAE
SXI
008060